Literature DB >> 1172484

Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

R Burger, U Hadding, H U Schorlemmer, V Brade, D Bitter-Suermann.   

Abstract

The polyanion dextran sulphate (DS) triggers the alternative pathway of complement. The influence of the molecular weight and degree of sulphation on this potency was studied. The degree of substitution turned out to be the critical parameter for optimal C3 turnover: 60 SO4/100 glucose units (Glc) showed optimal activity; an increase up to 190 SO4/100 Glc did not increase the activation potency, while lowering the degree of sulphation diminished this activity. DS preparations (120 SO4/100 Glc) of molecular weight: 1 x 10(4); 8 x 10(4); 2-5 x 10(5); 2 x 10(6) were equally active; a DS of molecular weight 5 x 10(3) was inactive. These results indicate that above a critical molecular size (greater than 5 x 10(3)) only the degree of substitution is responsible for the C3 activating capacity. Clusters of several glucose residues each carrying one or two sulphate groups are thought to be the essential structure in DS for the activation of the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1172484      PMCID: PMC1445957     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  4 in total

1.  Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation.

Authors:  U Hadding; M Dierich; W König; M Limbert; H U Schorlemmer; D Bitter-Suermann
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

2.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  DNP-antigens activate the alternate pathway of the complement system.

Authors:  W König; D Bitter-Suermann; M Dierich; M Limbert; H U Schorlemmer; U Hadding
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

4.  Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

Authors:  D Bitter-Suermann; M Dierich; W König; U Hadding
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

  4 in total
  14 in total

1.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

2.  The effect of dextransulfate 500 on the pathogenesis of herpes simplex virus infections in weanling mice.

Authors:  U Frank; L Caspary; H Hahn; D Falke
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

4.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  Studies on the mechanism of PMN activation. I. By dextran sulfates.

Authors:  J Müller; U Botzenhardt; P Alföldy; E M Lemmel
Journal:  Blut       Date:  1982-06

6.  Insoluble polyanions as activators of both pathways of complement.

Authors:  R Burger; D Bitter-Suermann; M Loos; U Hadding
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

7.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

8.  Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.

Authors:  A Kossorotow; W Opitz; E Etschenberg; U Hadding
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

9.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

10.  Toxicity of complement for chondrocytes. A possible source of cartilage degradation in inflammatory arthritis.

Authors:  S Satsuma; R A Scudamore; T D Cooke; W P Aston; R Saura
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.